Molecular mechanisms, functions and applications of RNA-guided DNA transposons
This project aims to enhance understanding of RNA-guided DNA transposons to develop advanced genome editing tools for biotechnology and precision medicine.
Projectdetails
Introduction
Genome engineering has transformed life science research and enabled revolutionary applications in biotechnology and medicine. Despite recent advances brought by the development of CRISPR-associated genome editing nucleases, a universal strategy for efficient site-specific gene editing and insertion in a range of organisms or cell types is currently unavailable.
Background
Transposons are natural genome remodelers and gene delivery vectors that modify and transfer genetic information across the tree of life by moving within and between their host genomes. To this end, they encode a vast and diverse reservoir of nucleic acid-targeting and -processing enzymes, whose molecular mechanisms are yet mostly unexplored.
Project Goals
Building on our recent structural and biochemical studies, the goal of this project is to advance our mechanistic knowledge of RNA-guided DNA transposons in order to understand their biology and guide their repurposing as next-generation genetic tools. Specifically, the proposed studies will investigate:
- The mechanisms of RNA-directed DNA mobilization of CRISPR-associated transposons (CASTs), aiming not only to provide insights into their molecular function but also to inform their technological development.
- The molecular activities and architectures of TnpB-like transposon proteins, recently identified putative RNA-guided endonucleases of prokaryotic and eukaryotic origin, with the ultimate goal of supporting their application as ultra-compact, broadly applicable genome editors.
- The translation of designer CASTs into a novel programmable DNA insertion technology for precision genomic profiling and engineering.
Impact
Altogether, the proposed studies will not only make key contributions to the molecular understanding and harnessing of RNA-guided transposons in nature and technologies, but hold the long-term potential to address current challenges in genome editing, biotechnologies, and precision medicine.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.499.403 |
Totale projectbegroting | € 1.499.403 |
Tijdlijn
Startdatum | 1-1-2024 |
Einddatum | 31-12-2028 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- UNIVERSITAT WIENpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Repurposing of CAST Systems as Next-Generation Tools for Genome Engineering of Mammalian CellsINTETOOLS aims to enhance genome engineering by repurposing CRISPR Associated Transposon systems for precise insertion of large DNA cargos in eukaryotic genomes, overcoming current limitations. | ERC Advanced... | € 2.475.491 | 2023 | Details |
RNA-based gene writing in human cellsSCRIBE aims to develop innovative RNA-based gene writing strategies using CRISPR and retrotransposons to enhance gene transfer efficacy and safety for research and therapeutic applications. | ERC Consolid... | € 1.999.465 | 2024 | Details |
Profile nucleases and Repurpose Off-Targets to Expand Gene EditingThe PROTÉGÉ project aims to enhance gene editing safety and diversity by profiling programmable nucleases and exploring off-target effects for improved precision in genetic therapies. | ERC Starting... | € 1.141.779 | 2023 | Details |
Visualizing trans-splicing molecular machines across scalesTRANSPLIC aims to elucidate the assembly and dynamics of trans-spliceosomes in Trypanosoma brucei using advanced imaging and functional assays, with implications for transcriptome editing. | ERC Consolid... | € 1.999.451 | 2025 | Details |
Harnessing a novel CRISPR nuclease for programmable counterselection in human cellsThis project aims to enhance CRISPR genome editing efficiency by developing a programmable counter-selection mechanism to eliminate unedited cells, thereby reducing screening burdens in various applications. | ERC Proof of... | € 150.000 | 2024 | Details |
Repurposing of CAST Systems as Next-Generation Tools for Genome Engineering of Mammalian Cells
INTETOOLS aims to enhance genome engineering by repurposing CRISPR Associated Transposon systems for precise insertion of large DNA cargos in eukaryotic genomes, overcoming current limitations.
RNA-based gene writing in human cells
SCRIBE aims to develop innovative RNA-based gene writing strategies using CRISPR and retrotransposons to enhance gene transfer efficacy and safety for research and therapeutic applications.
Profile nucleases and Repurpose Off-Targets to Expand Gene Editing
The PROTÉGÉ project aims to enhance gene editing safety and diversity by profiling programmable nucleases and exploring off-target effects for improved precision in genetic therapies.
Visualizing trans-splicing molecular machines across scales
TRANSPLIC aims to elucidate the assembly and dynamics of trans-spliceosomes in Trypanosoma brucei using advanced imaging and functional assays, with implications for transcriptome editing.
Harnessing a novel CRISPR nuclease for programmable counterselection in human cells
This project aims to enhance CRISPR genome editing efficiency by developing a programmable counter-selection mechanism to eliminate unedited cells, thereby reducing screening burdens in various applications.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A revolutionary cell programming platform based on the targeted nano-delivery of a transposon gene editing systemThe NANO-ENGINE project aims to develop an affordable, scalable, and safe DNA-based in vivo cell programming technology using Targeted Nanoparticles to enhance accessibility of cell therapies for various diseases. | EIC Pathfinder | € 2.988.377 | 2023 | Details |
Computation driven development of novel vivo-like-DNA-nanotransducers for biomolecules structure identificationThis project aims to develop DNA-nanotransducers for real-time detection and analysis of conformational changes in biomolecules, enhancing understanding of molecular dynamics and aiding drug discovery. | EIC Pathfinder | € 3.000.418 | 2022 | Details |
New Prime Editing and non-viral delivery strategies for Gene TherapyThis project aims to develop non-viral delivery systems and novel prime editors to enhance gene editing efficiency and safety for treating Sickle Cell Disease and other genetic disorders. | EIC Pathfinder | € 4.406.097 | 2022 | Details |
A revolutionary cell programming platform based on the targeted nano-delivery of a transposon gene editing system
The NANO-ENGINE project aims to develop an affordable, scalable, and safe DNA-based in vivo cell programming technology using Targeted Nanoparticles to enhance accessibility of cell therapies for various diseases.
Computation driven development of novel vivo-like-DNA-nanotransducers for biomolecules structure identification
This project aims to develop DNA-nanotransducers for real-time detection and analysis of conformational changes in biomolecules, enhancing understanding of molecular dynamics and aiding drug discovery.
New Prime Editing and non-viral delivery strategies for Gene Therapy
This project aims to develop non-viral delivery systems and novel prime editors to enhance gene editing efficiency and safety for treating Sickle Cell Disease and other genetic disorders.